BioRare Partners
BioRare Partners
  • Home
  • About Us
  • Services
  • Approach
  • Case Studies
  • Contact Us
  • Altro
    • Home
    • About Us
    • Services
    • Approach
    • Case Studies
    • Contact Us
  • Home
  • About Us
  • Services
  • Approach
  • Case Studies
  • Contact Us

Services - Tailored Expertise, Actionable Results.

Executive & Board Services

Regulatory & Product Development Advisory

Scientific & Preclinical Advisory

  • Executive as a service: fractional or interim (project-based)
  • Board member as a service and board advisory services

Scientific & Preclinical Advisory

Regulatory & Product Development Advisory

Scientific & Preclinical Advisory

  • Scientific and technical assessment of Biotech & MedTech assets
  • Preclinical planning and gap analysis
  • Early de-risking to enable funding and partnerships

Regulatory & Product Development Advisory

Regulatory & Product Development Advisory

Regulatory & Product Development Advisory

  • Regulatory roadmap (FDA/EMA for drugs, MDR & Notified Bodies for MedTech), orphan & fast track pathways
  • Clinical program and study design aligned with strategic objectives
  • Risk-adjusted development planning

Capital Strategy & Investor Support

Commercial Strategy and Business Planning

Regulatory & Product Development Advisory

  • Capital strategy and investment structure definition
  • Investor engagement, negotiation, and documentation support
  • Funding preparation: materials, data rooms, and financial scenarios

Business Development & Licensing

Commercial Strategy and Business Planning

Commercial Strategy and Business Planning

  •  Asset positioning and deal structuring
  • Partner identification and term sheet negotiation
  • CIMs, teasers, data rooms, and pitch decks

Commercial Strategy and Business Planning

Commercial Strategy and Business Planning

Commercial Strategy and Business Planning

  • Market assessment, sizing, and competitive analysis
  • Strategic positioning and go-to-market models
  • Forecasting, scenario modelling, and business plan development

Market Access, Pricing & Reimbursement

Medical Affairs Strategy & Scientific Support

Medical Affairs Strategy & Scientific Support

  • TPP refinement vs payer and procurement requirements
  • Pricing/access landscape (EU5, US, RoW) including DRG, bundled payments, value-based models
  • Value story & HTA risk mitigation across pharma and MedTech

Medical Affairs Strategy & Scientific Support

Medical Affairs Strategy & Scientific Support

Medical Affairs Strategy & Scientific Support

  • Evidence generation strategies for drugs and medical devices
  • Real-world data, registries, and post-market evidence planning
  • Medical Affairs and Clinical Affairs development and strategy

Copyright © 2025 BioRare Partners - All Rights Reserved

Gestito da

  • Privacy Policy

This website uses cookies.

 We use cookies to analyze website traffic and optimize your experience on the site. By accepting our use of cookies, your data will be aggregated with the data of all other users. 

DeclineAccept